Does UPADACITINIB Cause Swelling? 638 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 638 reports of Swelling have been filed in association with UPADACITINIB (Rinvoq). This represents 1.0% of all adverse event reports for UPADACITINIB.
638
Reports of Swelling with UPADACITINIB
1.0%
of all UPADACITINIB reports
84
Deaths
220
Hospitalizations
How Dangerous Is Swelling From UPADACITINIB?
Of the 638 reports, 84 (13.2%) resulted in death, 220 (34.5%) required hospitalization, and 88 (13.8%) were considered life-threatening.
Is Swelling Listed in the Official Label?
Yes, Swelling is listed as a known adverse reaction in the official FDA drug label for UPADACITINIB.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Swelling?
ADALIMUMAB (10,906)
METHOTREXATE (10,702)
ETANERCEPT (10,467)
TOCILIZUMAB (9,420)
ABATACEPT (9,226)
LEFLUNOMIDE (8,885)
RITUXIMAB (8,477)
PREDNISONE (7,968)
HYDROXYCHLOROQUINE (7,937)
CERTOLIZUMAB PEGOL (7,748)
Which UPADACITINIB Alternatives Have Lower Swelling Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL